Name: Pancragen

Alias: EDKP Tetrapeptide, Pancreatic Bioregulator Peptide CAS Registry number: N/A Sequence: Glu-Asp-Lys-Pro-OH Molecular Formula: C??H??N?O?? Molecular Weight: 506.51 Da Purity: ≥99% (by HPLC) Appearance: White lyophilized powder Packing: 20mg*10vials/box Product Group: Pancreatic epigenetic regulatory short peptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.

Brief Introduction:

Pancragen is a synthetic tetrapeptide belonging to the Khavinson organ-specific bioregulator family, exclusively for laboratory research. As a pancreas-targeted regulatory peptide, it penetrates cell and nuclear membranes to bind chromatin and regulate pancreatic gene transcription. It protects pancreatic acinar cells and islet cells from oxidative stress, inflammatory injury and age-related functional decline. It stabilizes pancreatic endocrine function, improves islet cell activity, optimizes glucose metabolism and maintains normal insulin secretion rhythm. It also alleviates pancreatic tissue inflammatory infiltration, reduces oxidative damage, and delays pancreatic organ aging. Widely applied in pancreatic protection, glucose metabolism regulation, islet cell function research, pancreatic inflammation and organ-specific epigenetic peptide studies.

Main Research Applications:

Pancreatic tissue protection research: Used in cell and animal models to study pancreatic cell anti-oxidation, anti-inflammation and damage repair mechanisms. Islet & glucose metabolism research: Suitable for exploring islet cell activity regulation, insulin balance and glycemic stability pathways. Pancreatic aging research: Applied to investigate pancreatic organ senescence delay and functional maintenance effects. Pancreatitis intervention research: For comparative analysis of pancreatic inflammatory injury relief and tissue microenvironment improvement.

Organ bioregulator pharmacology research: Study chromatin-targeted gene regulation characteristics of pancreatic-specific short peptides.